Participating Medical Centers
You have entered website for VIABLE study – phase III global clinical trial for prostate cancer treatment (DCVAC/PCa). This clinical trial is intended for patients with metastatic castration- resistant prostate cancer, who meet the entry criteria and consent to participate.
Only a physician conducting a clinical evaluation of an investigational treatment DCVAC/PCa can decide whether or not a patient can be included in a clinical trial. This is based on the criteria defined in the study protocol which is approved by the health care authorities.
The term “investigational treatment” means that it has not yet been approved by the European Medicines Agency (EMA) or Food and Drug Administration (FDA) for the treatment of prostate cancer.
You can find the participating medical centres listed below.
|Participating Medical Center||Address||Principal investigator||Phone|
|Instituto Português de Oncologia de Coimbra Francisco Gentil, E.P.E.
Avenida Bissaya Barreto, No. 98,
|Dr. Gabriela Sousa||+351 239 400 200|
|Hospital da CUF Descobertas -
José de Mello Saúde
Rue Mário Botas, Parque das Nações,
|Dr. João Paulo Fernandes||+351 210 025 650|
|Hospital da Luz
Avenida Lusíada, No. 100,
|Dr. Tânia Rodrigues||+351 217 104 400|
|Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E
Rua Dr. António Bernardino de Almeida,
|Dr. Nuno Sousa||+351 225 084 000|